Cargando…

Development and Validation of Prognostic Models to Estimate the Risk of Overt Hepatic Encephalopathy After TIPS Creation: A Multicenter Study

Overt hepatic encephalopathy (HE) is a major complication of transjugular intrahepatic portosystemic shunt (TIPS). This study aimed to develop and validate prognostic models to identify patients at different risks of overt HE within 3 months after TIPS. METHODS: Two cohorts of patients with cirrhosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chongtu, Zhu, Xiaoli, Liu, Jiacheng, Shi, Qin, Du, Hang, Chen, Yang, Huang, Songjiang, Zhou, Chen, Wang, Yingliang, Li, Tongqiang, Bai, Yaowei, Xiong, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963844/ https://www.ncbi.nlm.nih.gov/pubmed/35093957 http://dx.doi.org/10.14309/ctg.0000000000000461

Ejemplares similares

Portal flow diversion based on portography is superior than puncture site in the prediction of overt hepatic encephalopathy after TIPS creation
por: Yang, Chongtu, et al.
Publicado: (2022)

Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation model
por: Li, Tongqiang, et al.
Publicado: (2021)

Apatinib Plus Camrelizumab With/Without Chemoembolization for Hepatocellular Carcinoma: A Real-World Experience of a Single Center
por: Ju, Shuguang, et al.
Publicado: (2022)

Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
por: Li, Tongqiang, et al.
Publicado: (2021)

The impact of thrombocytopenia on variceal bleeding in cirrhotic patients with transjugular intrahepatic portosystemic shunt
por: Chen, Yang, et al.
Publicado: (2023)

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination
por: Ju, Shuguang, et al.
Publicado: (2022)

Management of traumatic peripheral artery pseudoaneurysm: A 10-year experience at a single center
por: Wang, Yingliang, et al.
Publicado: (2022)

Mild Prolongation of Prothrombin Time Does Not Affect the Safety and Prognosis of Transjugular Intrahepatic Portal Shunt: Based on Real-World Data
por: Bai, Yaowei, et al.
Publicado: (2023)

Increased Liquefactive Necrosis Formation After Transarterial Chemoembolization Combined with Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
por: Wang, Yingliang, et al.
Publicado: (2021)

Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt
por: Yang, Chongtu, et al.
Publicado: (2021)

A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy
por: Wang, Dongyuan, et al.
Publicado: (2022)

Changes and influencing factors of liver volume after transjugular intrahepatic portosystemic shunt: a retrospective cohort study
por: Bai, Yaowei, et al.
Publicado: (2023)

Transcatheter Arterial Embolization Containing Donafenib Induces Anti-Angiogenesis and Tumoricidal CD8(+) T-Cell Infiltration in Rabbit VX2 Liver Tumor
por: Shi, Qin, et al.
Publicado: (2021)

Dynamic Changes in the Aorta During the Cardiac Cycle Analyzed by ECG-Gated Computed Tomography
por: Zhu, Wenying, et al.
Publicado: (2022)

Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation
por: Liu, Jiacheng, et al.
Publicado: (2021)

Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy tests
por: Ehrenbauer, Alena F., et al.
Publicado: (2023)

Elevated carcinoembryonic antigen in patients with COVID-19 pneumonia
por: Yang, Chongtu, et al.
Publicado: (2020)

Effect of Inhibiting Tumor Angiogenesis After Embolization in the Treatment of HCC with Apatinib-Loaded p(N-Isopropyl-Acrylamide-co-Butyl Methyl Acrylate) Temperature-Sensitive Nanogel
por: Zhou, Chen, et al.
Publicado: (2020)

Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis
por: Wang, Chaoyang, et al.
Publicado: (2023)

Drug-Eluting Beads versus Lipiodol Transarterial Chemoembolization for the Treatment of Hypovascular Hepatocellular Carcinoma: A Single-Center Retrospective Study
por: Shi, Qin, et al.
Publicado: (2020)

COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study
por: Huang, Songjiang, et al.
Publicado: (2020)

Quantitative analysis based on chest CT classifies common and severe patients with coronavirus disease 2019 pneumonia in Wuhan, China
por: Yang, Chongtu, et al.
Publicado: (2021)

Hyponatremia: A Risk Factor for Early Overt Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation
por: Merola, Jonathan, et al.
Publicado: (2014)

Apatinib-loaded CalliSpheres Beads for embolization in a rabbit VX2 liver tumor: characterization in vitro, pharmacokinetics and tumor response in vivo
por: Shi, Qin, et al.
Publicado: (2020)

The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage
por: Liu, Jiacheng, et al.
Publicado: (2020)

A new choice of stent for transjugular intrahepatic portosystemic shunt creation: Viabahn ePTFE covered stent/bare metal stent combination
por: Liu, Jiacheng, et al.
Publicado: (2020)

Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis
por: Wang, Chaoyang, et al.
Publicado: (2022)

3D automatic liver and spleen assessment in predicting overt hepatic encephalopathy before TIPS: a multi-center study
por: Chen, Xiaoqiong, et al.
Publicado: (2023)

Molecular targeted therapy causes hepatic encephalopathy in patients after Transjugular intrahepatic portosystemic shunt (TIPS): A case report and literature review
por: Zhou, Chen, et al.
Publicado: (2022)

Primary Prophylaxis of Overt Hepatic Encephalopathy: Is It Time to Consider It?
por: Faccioli, Jessica, et al.
Publicado: (2023)

Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia
por: Yang, Chongtu, et al.
Publicado: (2021)

Usefulness of the Stroop Test in Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy
por: Hanai, Tatsunori, et al.
Publicado: (2021)

Disrupted Brain Intrinsic Networks and Executive Dysfunction in Cirrhotic Patients without Overt Hepatic Encephalopathy
por: Yang, Zhe-Ting, et al.
Publicado: (2018)

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
por: Roggeri, Daniela Paola, et al.
Publicado: (2015)

Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study
por: Yang, Yang, et al.
Publicado: (2021)

Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis
por: Bai, Zhaohui, et al.
Publicado: (2019)

Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis
por: Gairing, Simon J., et al.
Publicado: (2023)

Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization
por: Bai, Zhaohui, et al.
Publicado: (2019)

Association of preoperative IL-6 levels with overt HE in patients with cirrhosis after TIPS
por: Li, JinYu, et al.
Publicado: (2023)

Abnormal corpus callosum induced by overt hepatic encephalopathy impairs interhemispheric functional coordination in cirrhosis patients
por: Kuang, Yangying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k7vf2g4b7soojopduregl7r0ln